Evidence map›Paper›PMID 26614824›Full record

ArticleEuropean heart journal2016

One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry.

Miriam Puls, Edith Lubos, Peter Boekstegers, Ralph Stephan von Bardeleben, Taoufik Ouarrak, Christian Butter, Christine S Zuern, Raffi Bekeredjian, Horst Sievert, Georg Nickenig and 3 more

Abstract readEvaluation StudyMulticenter Study
In one paragraph

Article in European heart journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Mitral valve surgery after a failed MitraClip procedure.Interactive cardiovascular and thoracic surgery · 2021
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Functional status and quality of life after transcatheter mitral valve repair: a prospective cohort study and systematic review.Clinical research in cardiology : official journal of the German Cardiac Society · 2017
    Pooled it
  7. Safety and efficacy of the DragonFly system for transcatheter valve repair of degenerative mitral regurgitation: one-year results of the DRAGONFLY-DMR trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Trial
  8. Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022
    Trial
  9. Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2021
    Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Renal resistive index for risk stratification and functional evaluation after transcatheter mitral valve repair: the ReRISE study.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  20. Emergent Cardiac Surgery After Transcatheter Structural Heart Procedures: Narrative Review.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Review

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Miriam PulsHerzzentrum, Georg-August-Universität Göttingen, Göttingen, Germany dr.m.puls@med.uni-goettingen.de.
Edith LubosUniversitäres Herzzentrum Eppendorf Hamburg, Hamburg, Germany.
Peter BoekstegersKlinikum Siegburg (Kardiologie und Angiologie), Siegburg, Germany.
Ralph Stephan von BardelebenUniversitätsmedizin Mainz, 2. Med. Klinik, Mainz, Germany.
Taoufik OuarrakStiftung Institut für Herzinfarktforschung, Ludwigshafen, Germany.
Christian ButterHerzzentrum Brandenburg, Bernau, Germany.
Christine S ZuernUniversitätsklinikum Tübingen, Tübingen, Germany.
Raffi BekeredjianUniversitätsklinikum Heidelberg, Heidelberg, Germany.
Horst SievertCardio Vasculäres Centrum (CVC) Frankfurt St. Katharinen, Frankfurt am Main, Germany.
Georg NickenigUniversitätsklinikum Bonn (Med. Klinik und Poliklinik II), Bonn, Germany.
Holger EggebrechtCardioangiologisches Centrum Bethanien (CCB), Frankfurt am Main, Germany.
Jochen SengesStiftung Institut für Herzinfarktforschung, Ludwigshafen, Germany.
Wolfgang SchillingerHerzzentrum, Georg-August-Universität Göttingen, Göttingen, Germany Helios Albert-Schweitzer-Klinik Northeim, Northeim, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe transcatheter mitral valve interventions (TRAMI) registry was established in order to assess safety and efficacy of catheter-based mitral valve interventional techniques in Germany, and prospectively enrolled 828 MitraClip patients (median age 76 years, median log. EuroSCORE I 20.0%) between August 2010 and July 2013. We present the 1-year outcome in this MitraClip cohort-which is the largest published to date. METHODS AND

resultsSeven forty-nine patients (90.5%) were available for 1-year follow-up and included in the following analyses. Mortality, major adverse cardiovascular event rates, and New York Heart Association (NYHA) classes were recorded. Predictors of 1-year mortality were identified by multivariate analysis using a Cox regression model with stepwise forward selection. The 1-year mortality was 20.3%. At 1 year, 63.3% of TRAMI patients pertained to NYHA functional classes I or II (compared with 11.0% at baseline), and self-rated health status (on EuroQuol visual analogue scale) also improved significantly by 10 points. Importantly, a significant proportion of patients regained the complete independence in self-care after MitraClip implantation (independence in 74.0 vs. 58.6% at baseline, P = 0.005). Predictors of 1-year mortality were NYHA class IV (hazard ratio, HR 1.62, P = 0.02), anaemia (HR 2.44, P = 0.02), previous aortic valve intervention (HR 2.12, P = 0.002), serum creatinine ≥1.5 mg/dL (HR 1.77, P = 0.002), peripheral artery disease (HR 2.12, P = 0.0003), left ventricular ejection fraction <30% (HR 1.58, P = 0.01), severe tricuspid regurgitation (HR 1.84, P = 0.003), and procedural failure (defined as operator-reported failure, conversion to surgery, failure of clip placement, or residual post-procedural severe mitral regurgitation) (HR 4.36, P < 0.0001).

conclusionsTreatment of significant MR with MitraClip resulted in significant clinical improvements in a high proportion of TRAMI patients after 12 months. In the TRAMI cohort, the failure of procedural success exhibited the highest hazard ratio concerning the prediction of 1-year mortality.

Indexed as

Heart Valve ProsthesisAgedAged, 80 and overCardiac CatheterizationFemaleHeart FailureHeart Valve Prosthesis ImplantationHumansLength of StayMaleMitral Valve AnnuloplastyMitral Valve InsufficiencyQuality of LifeRegistriesTreatment OutcomeHeart failureMitraClipMitral valve regurgitationPercutaneous mitral valve repairTRAMI registry

Identifiers

PMID26614824
PMCPMC4761401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.